<?xml version="1.0" encoding="UTF-8"?>
<ref id="b25-1040138">
 <label>25.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moreau</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Pylypenko</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Grosicki</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study</article-title>. 
  <source>Lancet Oncol</source>. 
  <year>2011</year>;
  <volume>12</volume>(
  <issue>5</issue>):
  <fpage>431</fpage>â€“
  <lpage>440</lpage>.
  <pub-id pub-id-type="pmid">21507715</pub-id>
 </mixed-citation>
</ref>
